Personalized Cachexia Treatment and Monitoring System

A comprehensive system for personalized treatment and real-time monitoring of cachexia in patients undergoing surgery, utilizing customized immunonutrition supplements, wearable sensors, and machine learning algorithms to optimize treatment outcomes and reduce healthcare costs.

Cachexia, a severe body wasting condition, is a common complication of surgery, cancer, and infection. The original patent disclosed compositions and methods for treating or preventing surgery-induced cachexia. However, the existing approach has limitations, including a one-size-fits-all treatment approach and lack of real-time monitoring. The new inventive concept addresses these limitations by providing a personalized treatment system that adapts to individual patient needs and continuously monitors cachexia biomarkers.

The system comprises a patient profiling module, a nutrition supplement selection module, and an administration module. The patient profiling module identifies a patient's cachexia risk level and medical history. The nutrition supplement selection module selects a customized immunonutrition supplement based on the patient's risk level and medical history. The administration module ensures timely and accurate administration of the supplement. Additionally, a wearable sensor and data processing unit monitor cachexia biomarkers in real-time, providing alerts to healthcare providers when biomarkers exceed predetermined thresholds. A machine learning algorithm analyzes patient data to generate personalized cachexia risk profiles and predict treatment outcomes.

The new inventive concept introduces a paradigm shift from a one-size-fits-all approach to personalized treatment and real-time monitoring. The use of machine learning algorithms, wearable sensors, and customized immunonutrition supplements represents a significant departure from the original patent's composition-based approach. The inventive step lies in the integration of these components to create a comprehensive system that adapts to individual patient needs and optimizes treatment outcomes.

Alternative embodiments of the system could include the use of different types of sensors, such as implantable or ingestible sensors, or the integration of additional data sources, such as electronic health records or genomic data. Variations of the system could be designed for specific patient populations, such as pediatric or geriatric patients, or for different types of surgery or medical conditions.

The personalized cachexia treatment and monitoring system has significant commercial potential in the healthcare industry, particularly in the areas of surgical care, oncology, and nutrition therapy. The system could be marketed to hospitals, clinics, and healthcare providers, offering a competitive advantage in terms of improved treatment outcomes, reduced healthcare costs, and enhanced patient care.